NEA

Congratulations, @EchodyneCorp--to be acquired by defense tech company, @shieldaitech, for $5.3B! 🚀

NEA first partnered with Echodyne nearly a decade ago at the Series B. We're honored to have been on the journey with them as an early pioneer in MESA solid-state radar technology to becoming the global defense and commercial standard in drone detection radars. This acquisition will help power the next generation of defense tech! 🛡️

📰: prnewswire.com/news-releases/…

📢 Tomorrow! @NEA's Hunter Worland will be featured at the @TechCrunch Founder Summit 2026 in Boston on 11/4.

Catch Hunter on the Build Stage discussing 'The Next Startup Advantage: Distribution Beats Technology.'

🎟️ Register here for 50% discount: techcrunch.com/events/techcru…

🤑 The Annual @CBinsights Fintech 100 is out and highlights the most promising fintech startups of 2026 include @NEA portfolio companies: @Spiko_finance, Tokenz, and @DatabentoHQ--congratulations!

Details & full list: cbinsights.com/research/repor…

📢 @NEA's Hunter Worland will be featured at the @TechCrunch Founder Summit 2026 in Boston on 11/4. Catch Hunter on the Build Stage discussing 'The Next Startup Advantage: Distribution Beats Technology.'

🎟️ Register here for 50% discount: techcrunch.com/events/techcru…

Congratulations, @pathos AI--$237M Series E raised! 🎉

💡 Pathos’s Foundry platform uses thousands of AI agents to synthesize clinical, genomic, and competitive data in real time, helping steer drug programs toward the right patients and away from high-risk paths early.

🫱🏽‍🫲🏼 NEA first partnered with Pathos at the Series C, and we are thrilled to continue supporting the Pathos team as they work to transform drug development using proprietary patient data and AI to dramatically improve trial success rates and bring new hope to patients.

Details here: businesswire.com/news/home/2026…